PRC
DERM

Pearl River Capital’s Dermira, Inc. DERM Stock Holding History

Pearl River Capital’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,200
Closed -$16K – 965
2018
Q4 		$16K Buy
+2,200
New +$24.1K 0.07% 391

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pearl River Capital's DERM Position: Q1 2019 in Review

Pearl River Capital sold out of Dermira, Inc. (DERM) in Q1 2019, closing a stake of 2,200 shares — an estimated $16K sold.

Pearl River Capital first reported a position in DERM in Q4 2018 and held it in 1 quarter. The position peaked at $16K in Q4 2018. 144 funds tracked by Wall St. Rank hold DERM as of Q1 2019.

  • Pearl River Capital reported no remaining Dermira, Inc. position as of Q1 2019 after selling out during the quarter.
  • Pearl River Capital sold 2,200 Dermira, Inc. shares in Q1 2019, an estimated $16K.
  • Pearl River Capital first reported a position in Dermira, Inc. in Q4 2018 and held it in 1 quarter.
  • Pearl River Capital's Dermira, Inc. position peaked at $16K in Q4 2018.
  • 144 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2019.

Based on Pearl River Capital's 13F filing for Q1 2019, filed 2 May 2019.